MV4-11 Cells

The MV-4-11 cell line, isolated from the blast cells of a child with biphenotypic B-myelomonocytic leukemia, serves as a critical resource in the study of acute leukemias, particularly acute myeloid leukemia (AML). MV4-11 cells are characterized by their high proliferation rate and the presence of certain genetic abnormalities. A translocation between chromosomes 4 and 11 leads to the creation of the MLL-AF4 fusion gene, which plays a crucial role in leukemogenesis and contributes to the aggressive nature of leukemia. The presence of the MLL-AF4 fusion gene makes these cells particularly relevant for understanding the molecular mechanisms underlying leukemogenesis and studies on targeted therapies that aim to disrupt the function of this oncogenic fusion protein. Additionally, MV4-11 cells can be used to study the biology of leukemia stem cells, drug resistance mechanisms, and the role of the bone marrow microenvironment in leukemia progression. The cell line is further instrumental in metabolomics and transcriptomic profiles research, providing a comprehensive understanding of the metabolic alterations and redox adaptation in leukemia. The ability of MV-4-11 cells to respond to various cancer research chemicals, including inhibitors like venetoclax, and their role in studying resistant cells. In conclusion, the MV-4-11 cell line is a crucial tool in leukemia research, offering a versatile platform for investigating the complex biology of acute myeloid leukemia, testing the efficacy of therapeutic agents, and exploring the potential of targeted treatments in overcoming drug resistance. Leukemia cell lines, Blood, Acute monocytic leukemia, Growth Conditions: Suspension, Biosafety level: BSL 1